Excision BioTherapeutics
PrivateLast Round
Grant
Sep 29, 2022
Total Funding Raised
$76.85M
Company Overview
Excision BioTherapeutics is a biotechnology company developing CRISPR-based gene editing therapeutics to cure viral infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Excision BioTherapeutics Comparables
Compare Excision BioTherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| American Gene Technologies | 84% | |
| Shanghai Bendao Gene Technology | 77% | |
| Intellia Therapeutics | 75% | |
Excision BioTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 29, 2022 | ||||
| Series A | Feb 17, 2021 | ||||
| Seed | Sep 6, 2017 |
Excision BioTherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series A |
| Cota Capital | Series A |
| Gaingels | Series A |
| GreatPoint Ventures | Series A |
| WRVI Capital | Series A |
| ARTIS Ventures | Series A, Seed |
| Bioverge | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2025
Presented data at the ICE-HBV Hepatitis B Cure Symposium.
- Sep 17, 2025
EBT-107 program shows safety and potency for hepatitis B treatment.
Excision BioTherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Excision BioTherapeutics's valuation, stock price, and market status.